Akebia Therapeutics
AKBA
#7247
Rank
NZ$0.68 B
Marketcap
$3.12
Share price
-5.76%
Change (1 day)
43.27%
Change (1 year)

Revenue for Akebia Therapeutics (AKBA)

Revenue in 2024 (TTM): NZ$0.27 Billion

According to Akebia Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0.29 Billion. In 2023 the company made a revenue of NZ$0.30 Billion a decrease over the revenue in the year 2022 that were of NZ$0.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Akebia Therapeutics from 2013 to 2024

201620192022$0.1B$0.2B$0.3B$0.4B$0.5B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.27 B-10.93%
2023 NZ$0.30 B-33.08%
2022 NZ$0.45 B47.06%
2021 NZ$0.31 B-23.6%
2020 NZ$0.40 B-17.72%
2019 NZ$0.49 B60.61%
2018 NZ$0.30 B23.58%
2017 NZ$0.25 B11209.12%
2016 NZ$2.21 M
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$56.41 B 19,051.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$89.68 B 30,346.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$154.00 B 52,184.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.16 B-45.17%๐Ÿ‡บ๐Ÿ‡ธ USA